CClinicalTrials.gg
Active, not recruitingNCT07846098Updated Sep 29, 2026

Comparison of Intraosseous Anesthesia and Inferior Alveolar Nerve Block for Primary Mandibular Molars

An interventional study of Inferior Alveolar Nerve Block and intraosseous anaesthesia in Pain and Dental Caries, sponsored by Cumhuriyet University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 6 Years to 8 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Cumhuriyet University · Not applicable, Interventional, and Treatment

Updated Sep 29, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
6 Years to 8 Years
Sex
All
01

Study summary

The aim of the present study is to compare computerized intra-osseous injection system to the conventional inferior alveolar nerve block in primary mandibular teeth.

Read the detailed description

This study is designed as a randomized controlled clinical trial. A total of 60 primary mandibular molars from 30 pediatric patients who present for routine dental treatment at the Department of Pediatric Dentistry, Faculty of Dentistry, Sivas Cumhuriyet University, will be included. The study will consist of two sessions for each patient, with the type of anesthesia determined through simple randomization. In one session, traditional inferior alveolar nerve block anesthesia will be administered using a traditional syringe, and in the other session, intraosseous anesthesia will be performed using the computer-controlled SleeperOne5 device.

During anesthesia administration, pain levels will be assessed using the Visual Analog Scale (VAS), patient satisfaction will be evaluated with the Facial Image Scale (FIS), and behavior will be scored using the Modified Venham Scale. Additionally, heart rate, the volume of anesthetic solution used, and onset time of anesthesia will be recorded for both techniques. Postoperative complications will be assessed one day after the treatment.

02

Conditions studied

  • Pain
  • Dental Caries

Keywords

  • intraosseous anesthesia
  • inferior alveolar nerve block
  • primary molar teeth
03

In context

Pain

2,219 studies on the registry are indexed under Pain; 917 are open to participants now.

This study's planned enrollment of 30 is below the median of 70 across 1,904 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Cumhuriyet University is the lead sponsor of 128 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 8 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Children aged 6 to 8 years
  • Systemically healthy (American Society of Anesthesiologists [ASA] physical status I)
  • Positive or definitely positive behavior (Frankl Behavior Rating Scale score 3 or 4)
  • Bilateral (contralateral) mandibular primary molars with deep dentin caries requiring treatment
  • Able to attend a second appointment
  • Written informed consent from a parent/legal guardian and assent from the child

Exclusion criteria

Exclusion Criteria:

  • Known allergy to local anesthetic solutions
  • Use of analgesics within the last 24 hours
  • Acute infection
  • Gingivitis, oral fistula, abscess, or bone loss in the area where anesthesia will be administered
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    inferior alveolar nerve block

    Conventional inferior alvoelar nerve block anaesthesia will be given using a traditional metal syringe

    Other: Inferior Alveolar Nerve Block

  • Experimental
    intraosseous anaesthesia

    Computerized intraosseous anesthesia administration using SleeperOne5

    Other: intraosseous anaesthesia

Interventions

  • OtherInferior Alveolar Nerve Block

    inferior alveolar nerve block using Articaine 4% with 1/200000 Adrenaline and a traditional needle injection

  • Otherintraosseous anaesthesia

    intraosseous anaesthesia using Articaine 4% with 1/200000 Adrenaline and a special intraosseous injection device

06

What researchers measure

Primary outcomes

  1. Pain Intensity Measured by Visual Analog Scale (VAS)

    Pain intensity will be assessed using the Visual Analog Scale (VAS), a 10-cm horizontal line ranging from 0 (no pain) to 10 (worst possible pain). Scores range from 0 to 10, with higher scores indicating greater pain.

    Time frame: Immediately after anesthetic injection and during dental treatment (Day 1)

Secondary outcomes

  1. Heart Rate

    Heart rate will be measured in beats per minute (bpm) using a pulse oximeter.

    Time frame: Immediately before injection (baseline), during injection, and immediately after injection (Day 1)

  2. Dental Anxiety and Behavior Measured by Venham Clinical Anxiety Rating Scale

    Anxiety and behavior will be evaluated using the Venham Clinical Anxiety Rating Scale. Scores range from 0 (relaxed, cooperative) to 5 (out of contact, no response to verbal commands), with higher scores indicating greater anxiety and less cooperative behavior.

    Time frame: Immediately after anesthetic injection and during dental treatment (Day 1)

07

Study locations

1 site
  • Sivas Cumhuriyet University
    Sivas, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07846098
Lead sponsor
Cumhuriyet University
Responsible party
Arzu Koçkanat (Assistant Professor, Cumhuriyet University) — Principal investigator
First posted
Sep 29, 2026
Start date
May 14, 2026
Primary completion
Nov 20, 2026 (estimated)
Completion
Dec 20, 2026 (estimated)
Last update
Sep 29, 2026

Study contacts

Arzu Koçkanat, Asst.Prof.
principal investigator · Cumhuriyet University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion